OBJECTIVES: To examine 18-year trends in short-term and long-term stroke mortality and the prognostic influence of comorbidity. METHODS: We conducted a nationwide population-based cohort study. Using the Danish National Registry of Patients, covering all Danish hospitals, we identified all 219,354 patients with a first-time hospitalization for stroke during 1994-2011. We computed standardized 30-day, 1-year, and 5-year mortality by sex. Comorbidity categories were defined by Charlson Comorbidity Index scores of 0 (none), 1 (moderate), 2 (severe), and 3 or more (very severe). Calendar periods of diagnosis (1994-1998, 1999-2003, 2004-2008, and 2009-2011) and comorbidity categories were compared by means of mortality rate ratios based on Cox regression. RESULTS: Over time, the 30-day mortality rate ratio adjusted for age, sex, and comorbidity decreased by approximately 45% for ischemic stroke (standardized risk decreased from 17.2% in 1994-1998 to 10.6% in 2009-2011) and by 35% for intracerebral hemorrhage (from 43.2% to 33.8%). The absolute mortality reduction occurred for all levels of comorbidity. Five-year mortality risk decreased from 56.4% in 1994-1998 to 46.1% in 2004-2008 for ischemic stroke and from 66.1% to 61.0% for intracerebral hemorrhage. Comparing very severe comorbidity with no comorbidity, 30-day and 5-year mortality rate ratios were both approximately 2.5-fold increased for ischemic stroke and 1.7-fold increased for intracerebral hemorrhage. CONCLUSIONS: Short- and long-term mortality improved considerably between 1994 and 2011 for all types of stroke. Short-term mortality improved regardless of comorbidity burden. However, comorbidity burden was a strong prognostic factor for both short- and long-term mortality.
OBJECTIVES: To examine 18-year trends in short-term and long-term stroke mortality and the prognostic influence of comorbidity. METHODS: We conducted a nationwide population-based cohort study. Using the Danish National Registry of Patients, covering all Danish hospitals, we identified all 219,354 patients with a first-time hospitalization for stroke during 1994-2011. We computed standardized 30-day, 1-year, and 5-year mortality by sex. Comorbidity categories were defined by Charlson Comorbidity Index scores of 0 (none), 1 (moderate), 2 (severe), and 3 or more (very severe). Calendar periods of diagnosis (1994-1998, 1999-2003, 2004-2008, and 2009-2011) and comorbidity categories were compared by means of mortality rate ratios based on Cox regression. RESULTS: Over time, the 30-day mortality rate ratio adjusted for age, sex, and comorbidity decreased by approximately 45% for ischemic stroke (standardized risk decreased from 17.2% in 1994-1998 to 10.6% in 2009-2011) and by 35% for intracerebral hemorrhage (from 43.2% to 33.8%). The absolute mortality reduction occurred for all levels of comorbidity. Five-year mortality risk decreased from 56.4% in 1994-1998 to 46.1% in 2004-2008 for ischemic stroke and from 66.1% to 61.0% for intracerebral hemorrhage. Comparing very severe comorbidity with no comorbidity, 30-day and 5-year mortality rate ratios were both approximately 2.5-fold increased for ischemic stroke and 1.7-fold increased for intracerebral hemorrhage. CONCLUSIONS: Short- and long-term mortality improved considerably between 1994 and 2011 for all types of stroke. Short-term mortality improved regardless of comorbidity burden. However, comorbidity burden was a strong prognostic factor for both short- and long-term mortality.
Authors: Priscila Corraini; Victor W Henderson; Anne G Ording; Lars Pedersen; Erzsébet Horváth-Puhó; Henrik T Sørensen Journal: Stroke Date: 2016-11-29 Impact factor: 7.914
Authors: Lewis B Morgenstern; Devin L Brown; Melinda A Smith; Brisa N Sánchez; Darin B Zahuranec; Nelda Garcia; Kevin A Kerber; Lesli E Skolarus; William J Meurer; James F Burke; Eric E Adelman; Jonggyu Baek; Lynda D Lisabeth Journal: Stroke Date: 2014-07-29 Impact factor: 7.914
Authors: Hugo J Aparicio; Laura M Tarko; David Gagnon; Lauren Costa; Ashley Galloway; Serkalem Demissie; Luc Djousse; Sudha Seshadri; Kelly Cho; Peter W F Wilson Journal: Stroke Date: 2021-11-03 Impact factor: 7.914
Authors: Renée F A G de Bruijn; Michiel J Bos; Marileen L P Portegies; Albert Hofman; Oscar H Franco; Peter J Koudstaal; M Arfan Ikram Journal: BMC Med Date: 2015-07-21 Impact factor: 8.775
Authors: Lindsey R Kuohn; Audrey C Leasure; Julian N Acosta; Kevin Vanent; Santosh B Murthy; Hooman Kamel; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Neurology Date: 2020-09-11 Impact factor: 9.910
Authors: Marlena Schnieder; Mathias Bähr; Mareike Kirsch; Ilko Maier; Daniel Behme; Christian Heiner Riedel; Marios-Nikos Psychogios; Alex Brehm; Jan Liman; Christine A F von Arnim Journal: J Clin Med Date: 2021-05-18 Impact factor: 4.241